{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-007528","form_type":"8-K","ticker":"COSM","cik":"0001474167","company_name":"Cosmos Health Inc.","filed_at":"2023-10-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.176809+00:00","generated_at":"2026-06-10T02:15:12.494612+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Cosmos Health reports H1 2023 adjusted net income $3.01M, issues 2026 guidance of $180M revenue","bullets":["H1 2023 Adjusted EBITDA of $3.01M (up 182% YoY) and Adjusted Net Income of $3.01M (up from -$0.09M loss).","Inaugural 2026 guidance: gross annual revenue exceeding $180M and EBITDA >$20M.","Completed three acquisitions in 2023: Cana Laboratories, Bikas GP (adds >$10M annual revenue), and ZipDoctor.","Book value per share >$4 (2.5x current price); unencumbered properties fair value >$12M (>50% market cap).","CEO Greg Siokas invested >$15M total, ~$850K YTD; share buyback up to $3M started Sept 13."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-007528","json":"https://secwatch.observer/filing/0001477932-23-007528.json","markdown":"https://secwatch.observer/filing/0001477932-23-007528.md","text":"https://secwatch.observer/filing/0001477932-23-007528.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223007528/0001477932-23-007528-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1474167/000147793223007528/cosm_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T02:15:12.494612+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}